IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue273,957149,55576,436
Cost of Revenue1,868125,291
Gross Profit272,089149,54371,145
Operating Expenses
Research Development139,492108,746101,890
Selling General and Administrative183,112125,247118,333
Non Recurring37417,63820,292
Total Operating Expenses323,959--
Operating Income or Loss-51,870-102,088-169,370
Income from Continuing Operations
Total Other Income/Expenses Net9,315-9,485918
Earnings Before Interest and Taxes-42,555-111,573-168,452
Interest Expense39,15331,09621,166
Income Before Tax-81,708-142,669-189,618
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-81,708-142,669-189,618
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-81,708-142,669-189,618
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-81,708-142,669-189,618